Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS · Delayed Price · Currency is USD
0.000135
0.00 (0.00%)
At close: Oct 8, 2026
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $3.53 thousand as of October 14, 2026. It is the 52,122nd most valuable company in the world and the 8,150th biggest in the United States. Its market cap has increased by 13,492.31% in one year.
Market Cap
3.53K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,150 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from 10.98M to 3.53K, a decrease of -99.97%. That is a compound annual growth rate of -38.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 2.62K | - |
| Dec 31, 2025 | 2.62K | 9,969.23% |
| Dec 31, 2024 | 26.00 | -98.52% |
| Dec 29, 2023 | 1.75K | -33.00% |
| Dec 30, 2022 | 2.62K | -99.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Affimed | 4.92K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Evelo Biosciences | 3.80K |
| Synovics Pharmaceuticals | 3.65K |
| Rebus Holdings | 3.21K |